These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7086446)

  • 41. [The concentration of homovanillic acid and leucine-enkephalin in the lumbar CSF of patients with Parkinson's disease before and after madopar treatment].
    Liu DK
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Apr; 22(2):95-8, 126-7. PubMed ID: 2791764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Central nervous system gamma-aminobutyric acid activity in man. Relationship to age and sex as reflected in CSF.
    Hare TA; Wood JH; Manyam BV; Gerner RH; Ballenger JC; Post RM
    Arch Neurol; 1982 Apr; 39(4):247-9. PubMed ID: 7073535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study.
    Delgado-Alvarado M; Gago B; Gorostidi A; Jiménez-Urbieta H; Dacosta-Aguayo R; Navalpotro-Gómez I; Ruiz-Martínez J; Bergareche A; Martí-Massó JF; Martínez-Lage P; Izagirre A; Rodríguez-Oroz MC
    Mov Disord; 2017 Jul; 32(7):1066-1073. PubMed ID: 28548309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma and CSF GABA in affective illness.
    Berrettini WH; Nurnberger JI; Hare T; Gershon ES; Post RM
    Br J Psychiatry; 1982 Nov; 141():483-7. PubMed ID: 7150885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurotransmitter levels in cerebrospinal fluid in relation to severity of symptoms and response to medical therapy in Parkinson's disease.
    Ondarza R; Velasco F; Velasco M; Aceves J; Flores G
    Stereotact Funct Neurosurg; 1994; 62(1-4):90-7. PubMed ID: 7631094
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease.
    Happe S; Tings T; Helmschmied K; Neubert K; Wuttke W; Paulus W; Trenkwalder C
    Mov Disord; 2004 Dec; 19(12):1511-5. PubMed ID: 15390061
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cerebrospinal fluid levels of transition metals in patients with Parkinson's disease.
    Jiménez-Jiménez FJ; Molina JA; Aguilar MV; Meseguer I; Mateos-Vega CJ; González-Muñoz MJ; de Bustos F; Martínez-Salio A; Ortí-Pareja M; Zurdo M; Martínez-Para MC
    J Neural Transm (Vienna); 1998; 105(4-5):497-505. PubMed ID: 9720977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CSF GABA in caregiver spouses of Alzheimer patients.
    Pomara N; Deptula D; Galloway MP; LeWitt PA; Stanley M
    Am J Psychiatry; 1989 Jun; 146(6):787-8. PubMed ID: 2729431
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CSF gamma-aminobutyric acid in alcoholics and control subjects.
    Roy A; DeJong J; Ferraro T; Adinoff B; Ravitz B; Linnoila M
    Am J Psychiatry; 1990 Oct; 147(10):1294-6. PubMed ID: 2399995
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The immunological status in Parkinson's disease.
    Fiszer U; Piotrowska K; Korlak J; Członkowska A
    Med Lab Sci; 1991 Jul; 48(3):196-200. PubMed ID: 1787777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mitochondrial DNA in CSF distinguishes LRRK2 from idiopathic Parkinson's disease.
    Podlesniy P; Vilas D; Taylor P; Shaw LM; Tolosa E; Trullas R
    Neurobiol Dis; 2016 Oct; 94():10-7. PubMed ID: 27260835
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.
    Mondello S; Constantinescu R; Zetterberg H; Andreasson U; Holmberg B; Jeromin A
    Parkinsonism Relat Disord; 2014 Apr; 20(4):382-7. PubMed ID: 24507721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduced α-synuclein levels in cerebrospinal fluid in Parkinson's disease are unrelated to clinical and imaging measures of disease severity.
    van Dijk KD; Bidinosti M; Weiss A; Raijmakers P; Berendse HW; van de Berg WD
    Eur J Neurol; 2014 Mar; 21(3):388-94. PubMed ID: 23631635
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Parenteral application of NADH in Parkinson's disease: clinical improvement partially due to stimulation of endogenous levodopa biosynthesis.
    Kuhn W; Müller T; Winkel R; Danielczik S; Gerstner A; Häcker R; Mattern C; Przuntek H
    J Neural Transm (Vienna); 1996; 103(10):1187-93. PubMed ID: 9013405
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CSF levels of gamma-aminobutyric acid in schizophrenia. Low values in recently ill patients.
    van Kammen DP; Sternberg DE; Hare TA; Waters RN; Bunney WE
    Arch Gen Psychiatry; 1982 Jan; 39(1):91-7. PubMed ID: 7055411
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation of plasma and CSF prolactin with CSF GABA during neuroleptic treatment.
    Bowers MB; Meltzer HY; Heninger GR
    Life Sci; 1982 Jul; 31(1):59-65. PubMed ID: 6125865
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical implications of enzyme-mediated alterations of gamma-aminobutyric acid content in human CSF.
    Hare TA; Wood JH; Manyam BV
    Arch Neurol; 1981 Aug; 38(8):491-4. PubMed ID: 7247786
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EDTA inhibits in vitro increases in the GABA content of human CSF.
    Löscher W; Ahnfelt-Rønne I
    J Neurochem; 1982 Jul; 39(1):251-4. PubMed ID: 6806442
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low cerebrospinal fluid somatostatin in Parkinson disease: an irreversible abnormality.
    Dupont E; Christensen SE; Hansen AP; de Fine Olivarius B; Orskov H
    Neurology; 1982 Mar; 32(3):312-4. PubMed ID: 6121303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.